021-51111890
购物车（）
sales@molnova.cn
RRX-001
CAS No. 925206-65-1
RRX-001 ( RRX001;RRX 001 )
产品货号. M16629 CAS No. 925206-65-1
RRX-001 (RRX001) is a novel NO and hypoxia mediated anticancer agent with with epigenetic and immunologic activity.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥567 | 有现货 |
|
| 5MG | ￥948 | 有现货 |
|
| 10MG | ￥1256 | 有现货 |
|
| 25MG | ￥2373 | 有现货 |
|
| 50MG | ￥4155 | 有现货 |
|
| 100MG | ￥6059 | 有现货 |
|
| 500MG | ￥12636 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称RRX-001
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述RRX-001 (RRX001) is a novel NO and hypoxia mediated anticancer agent with with epigenetic and immunologic activity.
-
产品描述RRX-001 (RRX001) is a novel NO and hypoxia mediated anticancer agent with with epigenetic and immunologic activity; targets CD133 + /CD44 + cancer stem cells from colon cancer cell-lines, HT-29, Caco-2, and HCT116, and inhibits Wnt pathway signalling with downregulation of c-Myc; inhibits HCT 116 and decreases levels of the DNA methyltransferases DNMT1 and DNMT3a in a time and dose-dependent manner; RRX-001 (RRX001) is a chemosensitizer in multiple tumor types and disease states including malaria, hemorrhagic shock and sickle cell anemia.Lung Cancer Phase 2 Clinical
-
同义词RRX001;RRX 001
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Cancer
-
适应症Lung Cancer
化学信息
-
CAS Number925206-65-1
-
分子量268.02
-
分子式C5H6BrN3O5
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 100 mg/mL 373.11 mM
-
SMILESO=[N+](C1([N+]([O-])=O)CN(C(CBr)=O)C1)[O-]
-
化学全称2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Reid T, et al. Lancet Oncol. 2015 Sep;16(9):1133-1142. doi: 10.1016/S1470-2045(15)00089-3.
2. Scicinski J, et al. Redox Biol. 2015 Aug;5:422. doi: 10.1016/j.redox.2015.09.035.
3. Kim MM, et al. Transl Oncol. 2016 Apr;9(2):108-113.
4. Oronsky B, et al. Invest New Drugs. 2016 Jun;34(3):371-7.
2. Scicinski J, et al. Redox Biol. 2015 Aug;5:422. doi: 10.1016/j.redox.2015.09.035.
3. Kim MM, et al. Transl Oncol. 2016 Apr;9(2):108-113.
4. Oronsky B, et al. Invest New Drugs. 2016 Jun;34(3):371-7.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Gp100 (25-33), human...
Gp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells.
-
Incensole acetate
Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.
